Advanced search
Publication Cover
Transplant Research and Risk Management Volume 3, 2011 - Issue
Submit an article Journal homepage
18
Views
4
CrossRef citations to date
0
Altmetric
Review

Impact of everolimus: update on immunosuppressive therapy strategies and patient outcomes after renal transplantation

Helio Tedesco-Silva JrNephrology Division, Hospital do Rim e Hipertensão, Universidade Federal de São Paulo, BrazilCorrespondence[email protected]
,
Claudia Rosso FelipeNephrology Division, Hospital do Rim e Hipertensão, Universidade Federal de São Paulo, Brazil
,
Tainá Veras de Sandes FreitasNephrology Division, Hospital do Rim e Hipertensão, Universidade Federal de São Paulo, Brazil
,
Marina Pontello CristeliNephrology Division, Hospital do Rim e Hipertensão, Universidade Federal de São Paulo, Brazil
,
Carolina Araújo RodriguesNephrology Division, Hospital do Rim e Hipertensão, Universidade Federal de São Paulo, Brazil
&
José Osmar Medina PestanaNephrology Division, Hospital do Rim e Hipertensão, Universidade Federal de São Paulo, Brazil
Pages 9-29 | Published online: 24 Jan 2011

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Maurizio Salvadori & Elisabetta Bertoni. (2011) Long-term outcome of everolimus treatment in transplant patients. Transplant Research and Risk Management 3, pages 77-90.
Read now

Articles from other publishers (3)

Helio Tedesco-Silva, Faouzi Saliba, Markus J. Barten, Paolo De Simone, Luciano Potena, Jens Gottlieb, Apurva Gawai, Peter Bernhardt & Julio Pascual. (2022) An overview of the efficacy and safety of everolimus in adult solid organ transplant recipients. Transplantation Reviews 36:1, pages 100655.
Crossref
Claudia Felipe, Helio Tedesco-Silva, Alexandra Ferreira Brigido, Adrieli Bessa, Priscila Ruppel, Liliane Hiramoto, Mayara de Paula, Marina Cristelli, Suelen Stopa, Juliana Mansur, Laila Viana, Lucas Fahham, Camila Pepe & Jose Medina-Pestana. (2017) Cost-Effectiveness Analysis of Everolimus versus Mycophenolate in Kidney Transplant Recipients Receiving No Pharmacological Prophylaxis for Cytomegalovirus Infection: A Short-Term Pharmacoeconomic Evaluation (12 Months). Value in Health Regional Issues 14, pages 108-115.
Crossref
Heike Bittersohl & Werner Steimer. 2016. Personalized Immunosuppression in Transplantation. Personalized Immunosuppression in Transplantation 199 226 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.